SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy

<b>Background/Objectives</b>: As novel synergistic strategy for heart failure (HF), this study explores the formulation and characterization of liposomal systems co-loaded with SGLT2 inhibitors (dapagliflozin—DAPA and empagliflozin—EMPA) and curcumin (Cur). <b>Methods</b>: To enhance liposomal membr...

全面介紹

書目詳細資料

Principais autores:	Bianca-Ștefania Profire, Florentina Geanina Lupașcu, Alexandru Sava, Ioana-Andreea Turin-Moleavin, Dana Bejan, Cristian Stătescu, Victorița Șorodoc, Radu-Andy Sascău, Laurențiu Șorodoc, Mariana Pinteala, Lenuța Profire
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2025-07-01
叢編:	Pharmaceutics
主題:	SGLT2 inhibitors curcumin liposomes heart failure
在線閱讀:	https://www.mdpi.com/1999-4923/17/8/969
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!